US2014011210A1PendingUtilityA1
Actinobacillus suis antigens
Assignee: BOEHRINGER INGELHEIM VETMEDPriority: Nov 10, 2009Filed: Sep 16, 2013Published: Jan 9, 2014
Est. expiryNov 10, 2029(~3.3 yrs left)· nominal 20-yr term from priority
A61P 31/04A61P 37/04G01N 33/56911A61K 2039/552A61K 39/102
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides immunogenic compositions useful for inhibiting, treating, protecting, or preventing infection by Actinobacillus suis . These immunogenic compositions are demonstrated to usefully stimulate immunogenic responses in treated pigs. Some vaccines stimulated reactions sufficient to be protective against A. suis . In addition, the invention provides kits comprising the immunogenic compositions; as well as, methods of using the compositions and kits.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of diagnosing Actinobacillus suis infection in a subject, comprising
a) providing a filtered supernatant prepared by growing an A. suis culture to between 0.650 OD 650 and 0.850 OD 650 , collecting supernatant from the culture, and filtering the supernatant; b) contacting the filtered supernatant with a sample obtained from the subject; and c) identifying the subject as having an A. suis infection if an antibody capable of binding a component in the filtered supernatant is detected in the sample.
2 . The method of claim 1 , wherein the binding is detected using a second antibody capable of binding the antibody in the sample.Join the waitlist — get patent alerts
Track US2014011210A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.